Nasus Pharma Ltd Operating Expenses
Nasus Pharma Ltd (NSRX) reported Operating Expenses of $4.90 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-03-25
| Period end | Operating Expenses 6 month | Operating Expenses 12 month |
|---|---|---|
| 2025-12-31 | $4.90M 20-F · filed 2026-03-25 | |
| 2025-06-30 | $817.00K 6-K · filed 2025-12-29 | |
| 2024-12-31 | $1.08M 20-F · filed 2026-03-25 | |
| 2024-06-30 | $483.00K 6-K · filed 2025-12-29 | |
| 2023-12-31 | $1.15M 20-F · filed 2026-03-25 |